Special offer -20%

Zoetis
Simparica 40 mg for dogs between 10 and 20 kg 3 chewable tablets

Treatment of tick and flea infestations and treatment of sarcoptic mange in dogs

Prescription required* (Exceptions apply)

Simparica 40 mg are some mottled brown coloured, square shaped with rounded edges chewable tablets for the treatment of tick and flea infestations and treatment of sarcoptic mange in dogs.

Each Simparica 40 mg tablet contains:

Active substance:

  • Sarolaner 40 mg

Excipients:

  • Hypromellose acetate succinate, medium grade
  • Lactose monohydrate
  • Sodium starch glycolate
  • Silica, colloidal anhydrous
  • Magnesium stearate
  • Maize starch
  • Confectioner’s sugar
  • Glucose, liquid (81.5% solids)
  • Spray dried pork liver powder
  • Hydrolysed vegetable protein
  • Gelatin type A
  • Wheat germ
  • Calcium hydrogen phosphate anhydrous

Simparica 40 mg is indicated:

Dogs:

  • For the treatment of tick infestations (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus). The veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.
  • For the treatment of flea infestations (Ctenocephalides felis and Ctenocephalides canis). The veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. The veterinary medicinal product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
  • For the treatment of sarcoptic mange (Sarcoptes scabiei).

Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Simparica 40 mg posology:

For oral use.

Tablets can be administered with or without food.

The veterinary medicinal product should be administered at a dose of 2–4 mg/kg bodyweight in accordance with the following table:

Bodyweight(kg) Tablet strength (mg de sarolaner) Number of tablets to be administered
1.3 – 2.5 5 1
> 2.5 - 5 10 1
> 5 - 10 20 1
> 10 - 20 40 1
> 20 - 40 80 1
> 40 - 60 120 1
> 60 Appropriate combination of tablets

Use appropriate combination of available strengths to achieve the recommended dose of 2–4 mg/kg.

Simparica tablets are chewable and palatable and readily consumed by dogs when offered by the owner. If the tablet is not taken up voluntarily by the dog it can also be given with food or directly into the mouth. The tablets should not be divided.

  • Treatment schedule:
    • For optimal control of tick and fleas infestations, the veterinary medicinal product should be administered at monthly intervals and continue throughout the flea and/or tick season based on local epidemiological situations.
    • For the treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis) a single dose should be administered at monthly intervals for two consecutive months.

Simparica 40 mg are some mottled brown coloured, square shaped with rounded edges chewable tablets for the treatment of tick and flea infestations and treatment of sarcoptic mange in dogs.

Each Simparica 40 mg tablet contains:

Active substance:

  • Sarolaner 40 mg

Excipients:

  • Hypromellose acetate succinate, medium grade
  • Lactose monohydrate
  • Sodium starch glycolate
  • Silica, colloidal anhydrous
  • Magnesium stearate
  • Maize starch
  • Confectioner’s sugar
  • Glucose, liquid (81.5% solids)
  • Spray dried pork liver powder
  • Hydrolysed vegetable protein
  • Gelatin type A
  • Wheat germ
  • Calcium hydrogen phosphate anhydrous

Simparica 40 mg is indicated:

Dogs:

  • For the treatment of tick infestations (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus). The veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.
  • For the treatment of flea infestations (Ctenocephalides felis and Ctenocephalides canis). The veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. The veterinary medicinal product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
  • For the treatment of sarcoptic mange (Sarcoptes scabiei).

Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Simparica 40 mg posology:

For oral use.

Tablets can be administered with or without food.

The veterinary medicinal product should be administered at a dose of 2–4 mg/kg bodyweight in accordance with the following table:

Bodyweight(kg) Tablet strength (mg de sarolaner) Number of tablets to be administered
1.3 – 2.5 5 1
> 2.5 - 5 10 1
> 5 - 10 20 1
> 10 - 20 40 1
> 20 - 40 80 1
> 40 - 60 120 1
> 60 Appropriate combination of tablets

Use appropriate combination of available strengths to achieve the recommended dose of 2–4 mg/kg.

Simparica tablets are chewable and palatable and readily consumed by dogs when offered by the owner. If the tablet is not taken up voluntarily by the dog it can also be given with food or directly into the mouth. The tablets should not be divided.

  • Treatment schedule:
    • For optimal control of tick and fleas infestations, the veterinary medicinal product should be administered at monthly intervals and continue throughout the flea and/or tick season based on local epidemiological situations.
    • For the treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis) a single dose should be administered at monthly intervals for two consecutive months.
35.52
44.40 €
Order within 11h 10m 28s (before 12AM)
And receive your order
on Thursday 22 August
AIR FREIGHT

Customers who buy this product, usually buy: